Major Tumor Shrinking and Persistent Molecular Remissions After Consolidation With Bortezomib, Thalidomide, and Dexamethasone in Patients With Autografted Myeloma

Marco Ladetto, G Pagliano, Simone Ferrero, +17

Journal of Clinical Oncology

Cell TherapyAutografted MyelomaImmunologyPathologyImmunotherapy +17

Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myeloma

Güllü Görgün, Elisabetta Calabrese, Ender Soydan, +14

Blood

Regulation of Sclerostin Expression in Multiple Myeloma by Dkk-1: A Potential Therapeutic Strategy for Myeloma Bone Disease

Homare Eda, Loredana Santo, Marc N. Wein, +9

Journal of Bone and Mineral Research

Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma

Ola Landgren, Jonathan N. Hofmann, Charlene M. McShane, +18

JAMA Oncology

Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome

Marco Ladetto, Sonia Vallet, Andreas Trojan, +24

Blood

Preclinical activity of CPI-0610, a novel small-molecule bromodomain and extra-terminal protein inhibitor in the therapy of multiple myeloma

Ka Tat Siu, Janani Ramachandran, Andrew J. Yee, +7

Leukemia

Hematological MalignancyNovel Small-molecule BromodomainMedicineExtra-terminal Protein InhibitorImmunology +6

A novel Bruton’s tyrosine kinase inhibitor CC-292 in combination with the proteasome inhibitor carfilzomib impacts the bone microenvironment in a multiple myeloma model with resultant antimyeloma activity

Homare Eda, Loredana Santo, Diana Cirstea, +11

Leukemia

Hematological MalignancyOncologyResultant Antimyeloma ActivityMedicineImmunology +6

Pim2 is important for regulating DNA damage response in multiple myeloma cells

Janani Ramachandran, Loredana Santo, Ka Tat Siu, +2

Blood Cancer Journal

ApoptosisImmunologyCell DeathTumor BiologyMyeloid Neoplasia +16

Association between ABO and Duffy blood types and circulating chemokines and cytokines

Sarah C. Van Alsten, John G. Aversa, Loredana Santo, +6

Genes and Immunity

InflammationGranulocyteHematologyImmunologyPathology +7

Consolidation with Bortezomib, Thalidomide and Dexamethasone Induces Molecular Remissions in Autografted Multiple Myeloma Patients.

Marco Ladetto, G Pagliano, Ilaria Avonto, +14

Blood